232 related articles for article (PubMed ID: 21449913)
1. The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein.
Fiori JL; Sanghvi M; O'Connell MP; Krzysik-Walker SM; Moaddel R; Bernier M
Br J Pharmacol; 2011 Oct; 164(3):1026-40. PubMed ID: 21449913
[TBL] [Abstract][Full Text] [Related]
2. The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRα.
Krzysik-Walker SM; González-Mariscal I; Scheibye-Knudsen M; Indig FE; Bernier M
Mol Pharmacol; 2013 Jan; 83(1):157-66. PubMed ID: 23066093
[TBL] [Abstract][Full Text] [Related]
3. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.
Yang H; Wang Z; Capó-Aponte JE; Zhang F; Pan Z; Reinach PS
Exp Eye Res; 2010 Sep; 91(3):462-71. PubMed ID: 20619260
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
6. Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands.
Henriksen L; Grandal MV; Knudsen SL; van Deurs B; Grøvdal LM
PLoS One; 2013; 8(3):e58148. PubMed ID: 23472148
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y
Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719
[TBL] [Abstract][Full Text] [Related]
8. Antidote to cannabinoid intoxication: the CB
Pryce G; Baker D
Br J Pharmacol; 2017 Nov; 174(21):3790-3794. PubMed ID: 28800377
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.
Kokabu T; Mori T; Matsushima H; Yoriki K; Kataoka H; Tarumi Y; Kitawaki J
Cell Oncol (Dordr); 2019 Apr; 42(2):223-235. PubMed ID: 30706380
[TBL] [Abstract][Full Text] [Related]
10. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.
Reznik TE; Sang Y; Ma Y; Abounader R; Rosen EM; Xia S; Laterra J
Mol Cancer Res; 2008 Jan; 6(1):139-50. PubMed ID: 18234969
[TBL] [Abstract][Full Text] [Related]
11. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Sørensen BS; Tørring N; Bor MV; Nexø E
Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094
[TBL] [Abstract][Full Text] [Related]
12. Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane-anchored heparin-binding EGF-like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype.
Singh AB; Sugimoto K; Harris RC
J Biol Chem; 2007 Nov; 282(45):32890-901. PubMed ID: 17848576
[TBL] [Abstract][Full Text] [Related]
13. Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand.
Willy PJ; Murray IR; Qian J; Busch BB; Stevens WC; Martin R; Mohan R; Zhou S; Ordentlich P; Wei P; Sapp DW; Horlick RA; Heyman RA; Schulman IG
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8912-7. PubMed ID: 15184675
[TBL] [Abstract][Full Text] [Related]
14. Validation of HB-EGF and amphiregulin as targets for human cancer therapy.
Yotsumoto F; Yagi H; Suzuki SO; Oki E; Tsujioka H; Hachisuga T; Sonoda K; Kawarabayashi T; Mekada E; Miyamoto S
Biochem Biophys Res Commun; 2008 Jan; 365(3):555-61. PubMed ID: 18023415
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of EGFR ligands on endocytic sorting of the receptor.
Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
[TBL] [Abstract][Full Text] [Related]
16. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
Xu KP; Ding Y; Ling J; Dong Z; Yu FS
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):813-20. PubMed ID: 14985295
[TBL] [Abstract][Full Text] [Related]
17. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
Aveseh M; Nikooie R; Aminaie M
J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
[TBL] [Abstract][Full Text] [Related]
18. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo.
Rittié L; Varani J; Kang S; Voorhees JJ; Fisher GJ
J Invest Dermatol; 2006 Apr; 126(4):732-9. PubMed ID: 16470170
[TBL] [Abstract][Full Text] [Related]
19. Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptors.
Hudson BD; Hébert TE; Kelly ME
Br J Pharmacol; 2010 Jun; 160(3):627-42. PubMed ID: 20590567
[TBL] [Abstract][Full Text] [Related]
20. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.
Higashiyama S; Iwabuki H; Morimoto C; Hieda M; Inoue H; Matsushita N
Cancer Sci; 2008 Feb; 99(2):214-20. PubMed ID: 18271917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
